Nexalin Technology, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $3.6M
- Price
- $4.32
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.00%
- Volume
- 94.4K
About
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
Quick stats
Shares outstanding829.4K
Computed float709.7K
Float / shares85.6%
Cash runway (months)1.3
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001527352
Websitehttps://www.nexalin.com
AI Summary
AI-generated1/29
minorbullishproduct launch
Nuix Neo Generative AI Framework
Nuix announced the Nuix Neo Generative AI Framework, a governed orchestration layer for applying LLMs to enterprise structured and unstructured data with audit-grade telemetry, policy guardrails, and token-usage controls.
The framework powers two capabilities: Nuix Neo BYO AI, which systematically analyzes every item in a dataset with citable, forensically defensible reports, and the Nuix Neo AI Agent, a conversational investigation tool available now to early adopters via the Responsible Innovation Framework program.
The Los Angeles County District Attorney's Office is showcased as a reference customer integrating its chosen AI models into Nuix Neo workflows.
No revenue or bookings figures were disclosed, so the commercial impact of the launch remains unquantified.
Red flags
- AI Agent only at early-adopter stage; no revenue, bookings, or adoption metrics disclosed
- Release itself concedes Gen AI outputs remain probabilistic and require verification